Cited by 67Cancer, Hypoxia, and MetabolismBiochemical and Molecular ResearchAcute Myeloid Leukemia Research

ATF3 coordinates serine and nucleotide metabolism to drive cell cycle progression in acute myeloid leukemia

Open access
Di Marcantonio, Daniela, Martinez, Esteban, Kanefsky, Joice S., Huhn, Jacklyn M., Gabbasov, Rashid, Gupta, Anushk, Krais, John J., Peri, Suraj +8 more·2021·Molecular Cell

Abstract

Metabolic reprogramming is a common feature of many human cancers, including acute myeloid leukemia (AML). However, the upstream regulators that promote AML metabolic reprogramming and the benefits conferred to leukemia cells by these metabolic changes remain largely unknown. We report that the transcription factor ATF3 coordinates serine and nucleotide metabolism to maintain cell cycling, survival, and the differentiation blockade in AML. Analysis of mouse and human AML models demonstrate that ATF3 directly activates the transcription of genes encoding key enzymatic regulators of serine synthesis, one-carbon metabolism, and de novo purine and pyrimidine synthesis. Total steady-state polar metabolite and heavy isotope tracing analyses show that ATF3 inhibition reduces de novo serine synthesis, impedes the incorporation of serine-derived carbons into newly synthesized purines, and disrupts pyrimidine metabolism. Importantly, exogenous nucleotide supplementation mitigates the anti-leukemia effects of ATF3 inhibition. Together, these findings reveal the dependence of AML on ATF3-regulated serine and nucleotide metabolism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2021.05.008

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Di Marcantonio, D., Martinez, E., Kanefsky, J. S., Huhn, J. M., Gabbasov, R., Gupta, A., Krais, J. J., Peri, S., Tan, Y., Skorski, T., Dorrance, A., Garzon, R., Goldman, A. R., Tang, H.-Y., Johnson, N., & Sykes, S. M.
Affiliations
  • Fox Chase Cancer Center (US)
  • The Ohio State University Wexner Medical Center (US)
  • The Wistar Institute (US)
Corresponding author
Sykes, Stephen M.
Venue
Molecular Cell
Publisher
Elsevier BV
Published
2021-07
Volume
81
Issue
13
Pages
2752-2764.e6
ISSN
1097-2765 (ISSN-L)
OpenAlex
W3165884354
Cited by
67
References
51
Citations by year
2026: 9 · 2025: 18 · 2024: 12 · 2023: 17 · 2022: 9 · 2021: 2
FWCI
3.97
Type
journal article
Language
en
Open access
Locations
  • Molecular Cell (publishedVersion)
  • SSRN Electronic Journal (acceptedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (S10 OD023586, RSG-18-195-01-DDC, HL150190, CA010815, K99 CA241370, R01CA214799, R01 CA227830, CA237286, R01 CA244179, R50 CA221838, TRP 6565-19)
  • American Cancer Society (S10 OD023586, RSG-18-195-01-DDC, HL150190, CA010815, K99 CA241370, R01CA214799, R01 CA227830, CA237286, R01 CA244179, R50 CA221838, TRP 6565-19)
  • NHLBI (S10 OD023586, RSG-18-195-01-DDC, HL150190, CA010815, K99 CA241370, R01CA214799, R01 CA227830, CA237286, R01 CA244179, R50 CA221838, TRP 6565-19)
  • NCI (S10 OD023586, RSG-18-195-01-DDC, HL150190, CA010815, K99 CA241370, R01CA214799, R01 CA227830, CA237286, R01 CA244179, R50 CA221838, TRP 6565-19)
  • Leukemia and Lymphoma Society (S10 OD023586, RSG-18-195-01-DDC, HL150190, CA010815, K99 CA241370, R01CA214799, R01 CA227830, CA237286, R01 CA244179, R50 CA221838, TRP 6565-19)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Keywords
ATF3, acute myeloid leukemia, metabolic reprogramming, serine metabolism, nucleotide metabolism, one-carbon metabolism, purine biosynthesis, pyrimidine synthesis, cell cycle progression, transcriptional regulation, nucleotide supplementation, isotope tracing
MeSH terms
Cell Cycle, Humans, Neoplasm Proteins, Nucleotides, Serine, Leukemia, Myeloid, Acute, Cell Line, Tumor, Activating Transcription Factor 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review